Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01968876 · ClinicalTrials.gov registry record · Early Phase 1
Is a Smartphone Application Effective as an Oral Medication Adherence Aid
A Early Phase 1 study, sponsored by University of Arkansas.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 68
- Enrollment target
NCT01968876: Clinical Trial Early Phase 1 study, sponsored by University of Arkansas.
NCT01968876 is a Early Phase 1 study that was terminated before completion, run by University of Arkansas. The registered enrollment target is 68 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (28% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01968876, a Early Phase 1 study, was terminated before completion, sponsored by University of Arkansas.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 68 participants
- Enrollment target
Study Summary
This research will act as a pilot study that will be conducted to determine the effectiveness of a smartphone medication adherence application on adherence to oral hypertensive, diabetic, and dyslipidemic medications using a prospective randomized design. Subjects will be recruited from the University of Arkansas for Medical Sciences (UAMS) Internal Medicine Clinic North, and the study data will be collected using only subject self-reports and subject pharmacy records.
Interventions
- OTHER Medication Adherence Smartphone App
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2013-10-30 |
| Est. Completion | 2017-11-14 |
| Phase | Early Phase 1 |
Why NCT01968876 stopped before completion
NCT01968876 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (28% higher).
The record links to 0 conditions, and to 1 intervention - of which Medication Adherence Smartphone App is the first listed.
NCT01968876 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01968876 about?
NCT01968876 is a clinical study titled "Is a Smartphone Application Effective as an Oral Medication Adherence Aid". This research will act as a pilot study that will be conducted to determine the effectiveness of a smartphone medication adherence application on adherence to oral hypertensive, diabetic, and dyslipidemic medications using a prospective randomized design. Subjects will be recruited from the Universi...
What is the current status of trial NCT01968876?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 68 participants. The study started on 2013-10-30. Estimated completion is 2017-11-14.
What interventions are being tested in trial NCT01968876?
The interventions under investigation include: Medication Adherence Smartphone App (OTHER).
Who is sponsoring clinical trial NCT01968876?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01968876's enrollment target sits among peer trials
68 357th of 2000 higher than 1,639 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI